Appropriateness Criteria for Radiotherapy in the Setting of Presumed Early-stage Lung Cancer
This activity provides practitioners with the knowledge of the treatment of lung mass without tissue diagnosis.
Category
  • Thoracic
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Fine ART: Ever Evolving Online Adaptive Radiotherapy Technologies and Clinical Innovations
In the field of Adaptive Radiotherapy (ART), there are significant challenges in ensuring patient safety and treatment efficacy with the proper implementation of ART workflows and ART tools, effectively evaluating and implementing current clinical research, navigating the technical advancements a
Category
  • Adaptive RT
Format
  • Sessions onDemand
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $149.00
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
This activity focuses entirely on issues related to the Organs at Risk (OAR) in the setting of thoracic radiation. Discussion centers on protecting the OARs and managing acute and late toxicities. Each speaker focuses on a different clinical situation.
Category
  • Thoracic
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
A Randomized Study of Consolidation Chemoradiation (CTRT) versus Observation after first line chemotherapy (CT) in Advanced Gall Bladder Cancers (GBC): Race-GB Study
Management of unresectable gall bladder cancer (GBC) is challenging, and it can be especially so in Low-to-Middle Income Countries (LMIC), as <50% of patients complete the standard 6 cycles of CT.  This article presents the results of a single center, open label, randomized trial evaluating co
Category
  • Gastrointestinal
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $49.00
A Case-Based Interactive Discussion of the ASTRO Clinical Practice Guideline for HPV-Positive Oropharyngeal Squamous Cell Carcinoma
This case-based activity is designed to provide learners with practical guidance on management of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) and highlight areas of uncertainty where there may be a range of acceptable treatment approaches.
Category
  • Guidelines
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
The use of HPV ctDNA in the clinical management of patients with HPV-associated oropharyngeal squamous cell carcinoma is rapidly increasing; however, questions remain regarding its utility and validity in various clinical settings.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
eContouring for Primary Hepatobiliary Tumors
This eContouring activity reviews best practices for primary hepatobiliary contouring, including the integration of 4DCT imaging and MRI fusion.
Category
  • Gastrointestinal
Format
  • Sessions onDemand
  • Contouring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $179.00
Multimodality Treatment De-Intensification in Low-Risk Breast Cancer: What Are the Limits?
This is a case-based panel activity, with a surgeon, a medical oncologist and a radiation oncologist. Each speaker reviews the current and ongoing studies addressing treatment de-intensification in their area of expertise.
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Salvage Therapy for Local-Regional Breast Cancer Recurrence: What, When, and How Much?
Breast cancer recurrence after prior definitive multimodality treatment is an increasingly common clinical situation faced by practitioners, with long-term new primary or recurrent non-metastatic locoregional recurrence developing not infrequently over 10 years following initial treatment.
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Radiotherapy for Meningiomas – Where Do We Stand and What’s on the Horizon?
This activity aims to summarize current and anticipated developments, as well as active clinical trials related to the use of radiotherapy for meningiomas.
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $49.00

Pages